Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Diabetes, Obesity & Metabolism
|
January 10, 2025
Gastrointestinal tolerability and weight reduction associated with tirzepatide in adults with obesity or overweight with and without type 2 diabetes in the SURMOUNT-1 to -4 trials
Domenica M Rubino, Sue D Pedersen, Lisa Connery, et al.
Diabetes, Obesity & Metabolism
|
November 6, 2023
Tirzepatide reduces the predicted risk of atherosclerotic cardiovascular disease and improves cardiometabolic risk factors in adults with obesity or overweight: SURMOUNT-1 post hoc analysis
Emily R Hankosky, Hui Wang, Lisa M Neff, et al.
Cancers
|
January 18, 2020
Outcomes of Capecitabine and Temozolomide (CAPTEM) in Advanced Neuroendocrine Neoplasms (NENs)
Katharine Thomas, Brianne A Voros, Meghan Meadows-Taylor, et al.
BMC Geriatrics
|
March 27, 2024
Tools to measure barriers to medication management capacity in older adults: a scoping review
Bincy Baby, Annette McKinnon, Kirk Patterson, et al.
Mayo Clinic Proceedings. Digital Health
|
August 29, 2025
Medication Adherence Technologies: A Classification Taxonomy Based on Features
Bincy Baby, Jasdeep Kaur Gill, Sadaf Faisal, et al.
Diabetes, Obesity & Metabolism
|
March 8, 2026
Association of Tirzepatide With Kidney Parameters in Participants With Obesity and Prediabetes From SURMOUNT-1 Over 176 Weeks
Hiddo J L Heerspink, Daniel H van Raalte, Katherine Tuttle, et al.
Journal of the American Society of Nephrology : JASN
|
June 13, 2025
Kidney Parameters with Tirzepatide in Obesity with or without Type 2 Diabetes
Hiddo J L Heerspink, Allon N Friedman, Petter Bjornstad, et al.
Nature Medicine
|
May 12, 2026
Orforglipron for maintenance of body weight reduction: the double-blind, randomized phase 3b ATTAIN-MAINTAIN trial
Louis J Aronne, Deborah B Horn, Carel W le Roux, et al.
JMIR Aging
|
April 8, 2026
Personalized Predictive Model to Predict Subtask Success of Medication Adherence Technologies for Older Adults With Diverse Capabilities: Development and Internal Validation Study
Bincy Baby, Ghada Elba, Minzee Kim, et al.
BMJ Open
|
November 11, 2022
Induction of labour for predicted macrosomia: study protocol for the 'Big Baby' randomised controlled trial
Lauren Jade Ewington, Jason Gardosi, Ranjit Lall, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Diabetes, Obesity & Metabolism
|
January 10, 2025
Gastrointestinal tolerability and weight reduction associated with tirzepatide in adults with obesity or overweight with and without type 2 diabetes in the SURMOUNT-1 to -4 trials
Domenica M Rubino, Sue D Pedersen, Lisa Connery, et al.
Diabetes, Obesity & Metabolism
|
November 6, 2023
Tirzepatide reduces the predicted risk of atherosclerotic cardiovascular disease and improves cardiometabolic risk factors in adults with obesity or overweight: SURMOUNT-1 post hoc analysis
Emily R Hankosky, Hui Wang, Lisa M Neff, et al.
Cancers
|
January 18, 2020
Outcomes of Capecitabine and Temozolomide (CAPTEM) in Advanced Neuroendocrine Neoplasms (NENs)
Katharine Thomas, Brianne A Voros, Meghan Meadows-Taylor, et al.
BMC Geriatrics
|
March 27, 2024
Tools to measure barriers to medication management capacity in older adults: a scoping review
Bincy Baby, Annette McKinnon, Kirk Patterson, et al.
Mayo Clinic Proceedings. Digital Health
|
August 29, 2025
Medication Adherence Technologies: A Classification Taxonomy Based on Features
Bincy Baby, Jasdeep Kaur Gill, Sadaf Faisal, et al.
Diabetes, Obesity & Metabolism
|
March 8, 2026
Association of Tirzepatide With Kidney Parameters in Participants With Obesity and Prediabetes From SURMOUNT-1 Over 176 Weeks
Hiddo J L Heerspink, Daniel H van Raalte, Katherine Tuttle, et al.
Journal of the American Society of Nephrology : JASN
|
June 13, 2025
Kidney Parameters with Tirzepatide in Obesity with or without Type 2 Diabetes
Hiddo J L Heerspink, Allon N Friedman, Petter Bjornstad, et al.
Nature Medicine
|
May 12, 2026
Orforglipron for maintenance of body weight reduction: the double-blind, randomized phase 3b ATTAIN-MAINTAIN trial
Louis J Aronne, Deborah B Horn, Carel W le Roux, et al.
JMIR Aging
|
April 8, 2026
Personalized Predictive Model to Predict Subtask Success of Medication Adherence Technologies for Older Adults With Diverse Capabilities: Development and Internal Validation Study
Bincy Baby, Ghada Elba, Minzee Kim, et al.
BMJ Open
|
November 11, 2022
Induction of labour for predicted macrosomia: study protocol for the 'Big Baby' randomised controlled trial
Lauren Jade Ewington, Jason Gardosi, Ranjit Lall, et al.
Page
of 2